BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6142310)

  • 1. Lymphoma in organ transplant recipients.
    Lancet; 1984 Mar; 1(8377):601-3. PubMed ID: 6142310
    [No Abstract]   [Full Text] [Related]  

  • 2. Virus-induced lymphomas in transplant patients under immunosuppressive therapy.
    Touraine JL; Deteix P; el Yafi M; Traeger J; Dubernard JM; LeFrancois N; Lenoir G; de Thé G
    Transplant Proc; 1987 Oct; 19(5):4087-8. PubMed ID: 2823437
    [No Abstract]   [Full Text] [Related]  

  • 3. EBV-induced post-transplant lymphoproliferative disorder (PTLD).
    Birkeland SA; Hamilton-Dutoit S; Sandvej K; Andersen HM; Bendtzen K; Møller B; Jørgensen KA
    Transplant Proc; 1995 Dec; 27(6):3467-72. PubMed ID: 8540055
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.
    Starzl TE; Nalesnik MA; Porter KA; Ho M; Iwatsuki S; Griffith BP; Rosenthal JT; Hakala TR; Shaw BW; Hardesty RL
    Lancet; 1984 Mar; 1(8377):583-7. PubMed ID: 6142304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoproliferative disease in organ transplant recipients.
    Nalesnik MA
    Springer Semin Immunopathol; 1991; 13(2):199-216. PubMed ID: 1664986
    [No Abstract]   [Full Text] [Related]  

  • 6. [Viral infections in solid organ transplant recipients].
    Moreno MA
    Enferm Infecc Microbiol Clin; 1997 May; 15 Suppl 2():22-33. PubMed ID: 9312296
    [No Abstract]   [Full Text] [Related]  

  • 7. Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
    Ben-Ari Z; Amlot P; Lachmanan SR; Tur-Kaspa R; Rolles K; Burroughs AK
    Liver Transpl Surg; 1999 May; 5(3):184-91. PubMed ID: 10226108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of Immunosuppressive Therapy in Solid Organ Transplantation.
    Katabathina V; Menias CO; Pickhardt P; Lubner M; Prasad SR
    Radiol Clin North Am; 2016 Mar; 54(2):303-19. PubMed ID: 26896226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. Clonal analysis based on immunoglobulin-gene rearrangements.
    Cleary ML; Warnke R; Sklar J
    N Engl J Med; 1984 Feb; 310(8):477-82. PubMed ID: 6363929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular biology of lymphotropic herpesviruses.
    Sugden B; Kintner CR; Mark W
    Adv Cancer Res; 1979; 30():239-78. PubMed ID: 228536
    [No Abstract]   [Full Text] [Related]  

  • 11. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
    Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neoplasia in lung transplants].
    Blanco Aparicio M; Montero Martínez C
    Arch Bronconeumol; 2009 Aug; 45(8):363-5. PubMed ID: 19592149
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppressed solid organ transplant recipient.
    Stine JG; Shah N; Argo C
    Gastroenterology; 2014 Feb; 146(2):345,590. PubMed ID: 24342810
    [No Abstract]   [Full Text] [Related]  

  • 14. Transplant immunosuppression-related malignant lymphomas.
    Swinnen LJ
    Cancer Treat Res; 1993; 66():95-110. PubMed ID: 8102866
    [No Abstract]   [Full Text] [Related]  

  • 15. [Post-transplantation lymphomas and Epstein-Barr virus].
    Caillard S; Heibel F; Benaicha M; Moulin B
    Nephrologie; 1998; 19(8):481-8. PubMed ID: 9894641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder.
    Purighalla R; Shapiro R; Jordan ML; Scantlebury VP; Gritsch HA; Vivas C; Randhawa PS
    Clin Transplant; 1997 Dec; 11(6):574-6. PubMed ID: 9408687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases.
    Hauke RJ; Greiner TC; Smir BN; Vose JM; Tarantolo SR; Bashir RM; Bierman PJ
    Bone Marrow Transplant; 1998 Jun; 21(12):1271-4. PubMed ID: 9674863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphoproliferative disease and cancer in the transplant patient].
    Herreros J; Flórez S; Echevarría JR; Fernández AL; Pardo Mindán FJ
    Rev Esp Cardiol; 1995; 48 Suppl 7():129-34. PubMed ID: 8775827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral infections in renal transplant recipients: an evolutionary problem.
    Charpentier B
    Adv Nephrol Necker Hosp; 1986; 15():353-78. PubMed ID: 3006452
    [No Abstract]   [Full Text] [Related]  

  • 20. Overview of posttransplant B-cell lymphoproliferative disorders.
    Swinnen LJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):21-5. PubMed ID: 10561014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.